| 000 | 00995 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250512205315.0 | ||
| 264 | 0 | _c19830407 | |
| 008 | 198304s 0 0 fre d | ||
| 022 | _a0242-9462 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _ade Broucker, D | |
| 245 | 0 | 0 |
_a[Importance of the administration of synacthen (beta 1-24 corticotropin) in the therapeutic protocol of patients with neoplasms in an advanced stage]. _h[electronic resource] |
| 260 |
_bLARC medical _cOct 1982 |
||
| 300 |
_a806-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAdrenocorticotropic Hormone _xanalogs & derivatives |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aCosyntropin _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aGraux, P | |
| 773 | 0 |
_tLARC medical _gvol. 2 _gno. 9 _gp. 806-8 |
|
| 999 |
_c6298439 _d6298439 |
||